Search results
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Zacks via Yahoo Finance Canada· 6 days agoEli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi...
Opinion: Sometimes conspiracy theorists get things sort of right
The Globe and Mail· 6 days agoJen Gerson is a contributing columnist for The Globe and Mail. Spend too much time arguing on the...
Apellis' (APLS) Syfovre Boost Sales, Regulatory Setbacks a Woe
Zacks via Yahoo Finance Canada· 6 days agoApellis' (APLS) revenues rise on the back of the robust uptake of Syfovre for the GA indication....
Investors in AstraZeneca (LON:AZN) have seen strong returns of 115% over the past five years
Simply Wall St. via Yahoo Finance Canada· 6 days agoGenerally speaking the aim of active stock picking is to find companies that provide returns that...